PureTech Health LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for PureTech Health LLC.The latest application filed is for "methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation".

Company Profile

18.14.11

PureTech Health LLC - Boston MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods And Compositions For Treatment Of Disorders Ameliorated By Muscarinic Receptor Activation App 20200323839 - ELENKO; Eric ; et al.	2020-10-15
Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation Grant 10,695,339 - Elenko , et al.	2020-06-30
Deuterium-enriched Pirfenidone And Methods Of Use Thereof App 20200093810 - Elenko; Eric ; et al.	2020-03-26
Anti-galectin-9 Antibodies And Uses Thereof App 20200010551 - Koide; Shohei ; et al.	2020-01-09
Anti-galectin-9 antibodies and uses thereof Grant 10,450,374 - Koide , et al. Oc	2019-10-22
Methods And Compositions For Treatment Of Disorders Ameliorated By Muscarinic Receptor Activation App 20190307739 - ELENKO; Eric ; et al.	2019-10-10
Anti-galectin-9 Antibodies And Uses Thereof App 20190256604 - Koide; Shohei ; et al.	2019-08-22
Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation Grant 10,369,143 - Elenko , et al.	2019-08-06
Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation Grant 10,369,144 - Elenko , et al.	2019-08-06
Anti-Galectin-9 antibodies and uses thereof Grant 10,344,091 - Koide , et al. July 9, 2	2019-07-09
Methods And Compositions For Treatment Of Disorders Ameliorated By Muscarinic Receptor Activation App 20190192500 - ELENKO; Eric ; et al.	2019-06-27
Methods And Compositions For Treatment Of Disorders Ameliorated By Muscarinic Receptor Activation App 20190167658 - ELENKO; Eric ; et al.	2019-06-06
Anti-galectin-9 Antibodies And Uses Thereof App 20190127472 - Koide; Shohei ; et al.	2019-05-02
Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation Grant 10,265,311 - Elenko , et al.	2019-04-23
Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation Grant 10,238,643 - Elenko , et al.	2019-03-26
Exosomes For Delivery Of Therapeutic Agents App 20180193270 - Bolen; Joseph ; et al.	2018-07-12
Methods And Compositions For Treatment Of Disorders Ameliorated By Muscarinic Receptor Activation App 20170112820 - Elenko; Eric ; et al.	2017-04-27
Methods And Compositions For Treatment Of Disorders Ameliorated By Muscarinic Receptor Activation App 20170095465 - Elenko; Eric ; et al.	2017-04-06

Company Registrations

NCAGE Code	5H8H4	PURETECH HEALTH LLC!DBA BIO PHARMACEUTICAL
CAGE Code	5H8H4	PURETECH HEALTH LLC BIO PHARMACEUTICAL
S.A.M. Registration	5H8H4 [139747096]	PURETECH HEALTH LLC BIO PHARMACEUTICAL
SEC	0001727395	PureTech Health LLC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.